Capture phrases in quotes for more specific queries (e.g. "rocket ship" or "Fred Lynn")


Lymphoma treatment: Targretin® (bexarotene)

SRI and the La Jolla Cancer Research Foundation (now the Sanford-Burnham Research Institute) collaborated on work that resulted in patent filings for the drug bexarotene, approved in 1999 by the Food and Drug Administration to treat cutaneous T-cell lymphoma—a rare disorder of the immune system where T-cells, a type of white blood cell that fights infections and other diseases, become cancerous and affect the skin and blood.

close check icon

Message Sent

Success! - Thank you for your interest.


SRI and its partners use cookies to improve your browsing experience. If you continue to use this website without changing your cookie settings, you are consenting to the use of cookies by SRI and its partners. For more information on SRI’s privacy practices, including how to decline the use of cookies, please read our Privacy Statement.

I agree
share dwonload plus email external external project copy play call directions linkedin